Getting beyond the immunotherapy divide

Advances in the field of tumor immunotherapy have given great hope for those treating cancer. We are in an era of unprecedented achievements, as evidenced by impressive clinical responses in patients treated with adoptive cell therapy and immune checkpoint inhibitors. One could look no further than the ever-increasing numbers of lung cancer immunotherapy trials to see the excitement in the field of cancer. Many patients believe that the new immunotherapies are the “miracle…

Continue Reading

Hong, Tossas-Milligan discuss cancer funding on Capitol Hill

Illinois currently has two National Cancer Institute-designated cancer centers, but the state needs a cancer center in a public institution such as the University of Illinois at Chicago to ensure access to excellent cancer care for all. That was the message federal lawmakers in Washington heard last week from Kathy Tossas-Milligan, PhD, MS, Office of Global Assets and Innovative Approaches at the UI Cancer Center, and Susan Hong, MD, director of survivorship, during…

Continue Reading